☰ Menu

Imperial College London

Imperial College London is a science-based university with an international reputation for excellence in teaching and research.
Consistently rated amongst the world’s best universities, Imperial is committed to developing the next generation of researchers, scientists and academics through collaboration across disciplines.
Located in the heart of London, Imperial is a multidisciplinary space for education, research, translation and commercialisation, harnessing science and innovation to tackle global challenges.

The AHSC encompasses the Imperial College Faculties – in Medicine, Natural Sciences, Engineering and the Business School. The Faculty of Medicine is one of Europe’s largest medical schools, with 470 academic staff and equivalent numbers holding honorary contracts), and 1,300 undergraduate and postgraduate students (2011/12). Ranked 3rd in Europe and 4th in the world for clinical, pre-clinical and health (Times Higher Education World University Rankings 2014-15). Among the Faculty’s staff are 10 Fellows of the Royal Society 2013, 76 Fellows of the Academy of Medical Sciences, 20 National Institute Health Research (NIHR) Senior Investigators and 16 Wellcome Trust Investigators

Imperial College Healthcare NHS Trust

Imperial College Healthcare NHS Trust was formed on October 1, 2007 by merging St Mary’s NHS Trust and Hammersmith Hospitals NHS Trust and integrating with the faculty of medicine at Imperial College London. With more than one million patient contacts each year, it is one of the largest acute Trusts in the country. There are five Imperial College Healthcare NHS Trust hospitals: Charing Cross HospitalHammersmith HospitalQueen Charlotte’s & Chelsea HospitalSt Mary’s Hospital and theWestern Eye Hospital .

Royal Brompton & Harefield NHS Foundation Trust

The Royal Brompton & Harefield NHS Foundation Trust is a national and international specialist heart and lung centre based in Chelsea, London and Harefiled, Middlesex. The Trust helps patients from all age groups who have heart and lung problems and is the country’s largest centre for the treatement of adult congenital heart disease.

Royal Marsden NHS Foundation Trust

The Royal Marsden opened its doors in 1851 as the world’s first hospital dedicated to cancer diagnosis, treatment, research and education. Today, together with its academic partner, The Institute of Cancer Research (ICR), it is the largest and most comprehensive cancer centre in Europe treating over 50,000 NHS and private patients every year.  It is a centre of excellence with an international reputation for groundbreaking research and pioneering the very latest in cancer treatments and technologies. The Royal Marsden, with the ICR, is the only National Institute for Health Research Biomedical Research Centre for Cancer, supporting pioneering research work carried out over a number of different cancer themes.

Expansion group photo sel_6590

Back row (left to right): Mr Piers McCleery (Director of Strategy and Planning, RBHT), Dr Richard Grocott-Mason (Medical Director, RBHT), Dr Nicholas van As (Medical Director, RMH), Professor Janice Sigsworth (Director of Nursing, ICHT), Dr Julian Redhead (Medical Director, ICHT), Dr Angela Cooper (AHSC Programme Director), Mr Nigel Buck (COO, Imperial College London), Ms Laura Wooler (AHSC Secretariat) Front row (left to right): Dr Tracey Batten (CEO, ICHT), Mr Robert Bell (CEO, RBHT), Ms Cally Palmer (CEO , RMH), Professor Jonathan Weber (AHSC Director)